CORBUS PHARMACEUTICALS HLDGS's ticker is CRBP and the CUSIP is 21833P103. A total of 103 filers reported holding CORBUS PHARMACEUTICALS HLDGS in Q1 2019. The put-call ratio across all filers is 1.39 and the average weighting 0.3%.
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Ikarian Capital, LLC | 397,168 | $43,888 | 0.01% |
| CJM Wealth Advisers, Ltd. | 30,465 | $3,366 | 0.00% |
| Tekla Capital Management LLC | 154,310 | $17,051 | 0.00% |
| McAdam, LLC | 10,006 | $6 | 0.00% |
| Aries Wealth Management | 15,400 | $1,702 | 0.00% |
| WELLS FARGO & COMPANY/MN | 342,084 | $37,800 | 0.00% |
| JPMORGAN CHASE & CO | 43,415 | $5 | 0.00% |
| NORTHERN TRUST CORP | 207,329 | $22,910 | 0.00% |
| PINNACLE ASSOCIATES LTD | 18,580 | $2,053 | 0.00% |
| CONCOURSE FINANCIAL GROUP SECURITIES, INC. | 0 | $0 | 0.00% |